In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients.
Rusconi
S
S
Clinica delle Malattic Infettive, Università di Milano, Ospedale Luigi Sacco, Italy.
Riva
A
A
Cocchi
F
F
Massironi
E
E
Tornaghi
R
R
de Maddalena
C
C
de Pasquale
M P
MP
Galli
M
M
D000918:Antibody Specificity / Q000276:immunology; D018791:CD4 Lymphocyte Count; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D015483:HIV Antibodies / Q000378:metabolism*; D016655:HIV Core Protein p24 / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D019302:HIV Envelope Protein gp160 / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D066298:In Vitro Techniques; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009000:Monocytes / Q000276:immunology; D011379:Prognosis
D015483:HIV Antibodies; D016655:HIV Core Protein p24; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41; D007074:Immunoglobulin G